Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Heiser

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Nature Communications|June 21, 2022
A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signalingCemal Erdem, Arnab Mutsuddy, Ethan M Bensman, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Cell Reports|January 1, 2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancerKaylyn L Devlin, Rebecca Smith, Elmar Bucher, et al.
Scientific Reports|March 9, 2019
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancerDaniel J Coleman, Lina Gao, Jacob Schwartzman, et al.
Cellular Signalling|November 7, 2023
Functional delineation of the luminal epithelial microenvironment in breast using cell-based screening in combinatorial microenvironmentsTiina A Jokela, Mark A Dane, Rebecca L Smith, et al.
Oncotarget|December 2, 2015
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinomaHui-Wen Lue, Brook Cole, Soumya A M Rao, et al.
Oncogene|April 19, 2019
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancerDaniel J Coleman, Lina Gao, Carly J King, et al.
Cell Reports. Medicine|June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinomaHui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Nature Communications|June 21, 2022
A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signalingCemal Erdem, Arnab Mutsuddy, Ethan M Bensman, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Cell Reports|January 1, 2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancerKaylyn L Devlin, Rebecca Smith, Elmar Bucher, et al.
Scientific Reports|March 9, 2019
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancerDaniel J Coleman, Lina Gao, Jacob Schwartzman, et al.
Cellular Signalling|November 7, 2023
Functional delineation of the luminal epithelial microenvironment in breast using cell-based screening in combinatorial microenvironmentsTiina A Jokela, Mark A Dane, Rebecca L Smith, et al.
Oncotarget|December 2, 2015
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinomaHui-Wen Lue, Brook Cole, Soumya A M Rao, et al.
Oncogene|April 19, 2019
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancerDaniel J Coleman, Lina Gao, Carly J King, et al.
Cell Reports. Medicine|June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinomaHui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Pageof 10